A Study to evaluate the pain killing properties of yastimadhu suppository.

A randomized comparative clinical study to evaluate the efficacy of Yastimadhu rectal suppository over Diclofenac sodium rectal suppository in the post operative pain management of Fissurectomy. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083082

Enrollment

Registered

2025-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical features of chronic solitary fissure in ano who have undergone fissurectomy.

Exclusion criteria

Exclusion criteria: Patients with systemic disorders like uncontrolled diabetes and hypertension Patients with underlying renal pathologies. Patients with other anorectal pathologies like carcinoma of rectum hemorrhoids acute fissures etc.

Design outcomes

Primary

Measure	Time frame
pain reliefTimepoint: 7 days	—

Secondary

Measure	Time frame
pain reliefTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Sachin Badiger

BLDEAs AVS Ayurveda Mahavidyalaya Vijayapura

anees8804@gmail.com9538140448

Outcome results